Randomized, Double-Blind Study of the Safety, Tolerability, and Efficacy of Tafenoquine versus Mefloquine for Malaria Prophylaxis in Nonimmune Subjects - Nasveld, Peter E.; Edstein, Michael D.; Reid, Mark; Brennan, Leonard; Harris, Ivor E.; Kitchener, Scott J.; Leggat, Peter A.; Pickford, Philip; Kerr, Caron; Ohrt, Colin; Prescott, William (Antimicrobial Agents and Chemotherapy, 2010)
Keywords: Adult; Aminoquinolines; Aminoquinolines - adverse effects; Aminoquinolines - therapeutic use; Antibiotics. Antiinfectious agents. Antiparasitic agents; Antimalarials; Antimalarials - adverse effects; Antimalarials - therapeutic use; Australia; Biological and medical sciences; Clinical Therapeutics; Double-Blind Method; Female; Human protozoal diseases; Humans; Infectious diseases; Malaria; Malaria - drug therapy; Male; Medical sciences; Mefloquine; Mefloquine - adverse effects; Mefloquine - therapeutic use; Middle Aged; Military Personnel; Parasitic diseases; Pharmacology. Drug treatments; Plasmodium vivax; Protozoal diseases; Treatment Outcome; Young Adult; Australia; East Timor; Human; Antimalarial; Protozoal disease; Mefloquine; Malaria; Toxicity; Treatment efficiency; Parasitosis; Infection; Prevention; Tafenoquine; Randomization; Double blind study; Parasiticide; Safety; Comparative study